{
  "first_published_at": "2010-07-01", 
  "original_url": "http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON088171", 
  "title": "Intravenous paracetamol (Perfalgan ▼): risk of accidental overdose, especially in infants and neonates", 
  "tags": "{\"parsed_therapeutic\": [\"pain-management-palliation\", \"paediatrics-neonatology\"], \"Audience:\": [\"Secondary care\"], \"Therapeutic area:\": [\"Pain management and palliation\", \"Paediatrics and neonatology\"]}", 
  "_document_number": 194, 
  "label": null, 
  "icon": "http://www.mhra.gov.uk/home/images/MHRALook/img/dsu/dose_icon.png", 
  "therapeutic_area": [
    "pain-management-palliation", 
    "paediatrics-neonatology"
  ], 
  "raw_html": "<div id=\"dsuArticleContent\">\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\t<h1><a name=\"maincontent\" id=\"maincontent\"></a>Intravenous paracetamol (Perfalgan &#9660;): risk of accidental overdose, especially in infants and neonates</h1>\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<span class=\"ref\">Article date: July 2010</span> \r\n\t\t\t\t\t\t\t\t<!--SS_BEGIN_ELEMENT(region1_element21)-->\r\n\t\t\t\t\t\t\t\t<!---->\r\n\t\t\t\t\t\t\t\t<!--SS_END_ELEMENT(region1_element21)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!--SS_BEGIN_ELEMENT(region1_element22)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!--SS_END_ELEMENT(region1_element22)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<div id=\"dsuSynopsis\" class=\"yellow\">\r\n\t\t\t\t\t\t\t\t\t<div class=\"dsuArticlePadding\">\r\n\t\t\t\t\t\t\t\t\t<span id=\"dsuSynopsisTitle\"><b>Summary</b></span>\t\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\t<br>Vigilance is advised when prescribing and administering intravenous paracetamol 10 mg/mL solution for infusion (Perfalgan &#9660;) to ensure that the correct dose is given. For all patients, dose requirement is based on weight as outlined below and in the product information. For infants and children who weigh less than 33 kg, the 50 mL vial should be used for administration<br>\t\r\n\t\t\t\t\t\t\t\t\t</div>         \t\t\r\n\t\t\t\t\t\t\t\t\t<div id=\"dsuSynopsisCut\">\r\n\t\t\t\t\t\t\t\t\t</div>\r\n\t\t\t\t\t\t\t\t</div>\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!--SS_BEGIN_ELEMENT(region1_element13)-->\r\n\t\t\t\t\t\t\t\t<!--<p>Cases of accidental overdose have been reported during treatment with intravenous paracetamol 10 mg/mL solution for infusion (Perfalgan &#9660;). In most cases, this occurred in infants and neonates due to confusion between the prescription of Perfalgan being issued in mg and then administered in mL; in most of these cases, a 10-fold overdose was reported.</p><p>Perfalgan is indicated for the short-term treatment of pain and fever, when there is a clinical need of paracetamol administration intravenously. It is available as a solution for infusion of 10 mg paracetamol per 1 mL solution in 50 mL vials and 100 mL vials. The 50 mL vial is only for use in term newborn infants, infants, toddlers, and children who weigh less than 33 kg.</p><p>The recommended dose of Perfalgan depends on the weight of the patient, and is summarised in the table below.</p><p><strong>Note</strong> that irrespective of dose, the dosing schedule is up to four infusions a day with a minimum of 4 hours between each administration (6 hours for those with renal impairment).</p><table class=\"standard\">\r\n\t\t\t<tbody>\r\n\t\t\t\t<tr>\r\n\t\t\t\t\t<th></th>\r\n\t\t\t\t\t<th>Term newborn infants, infants, toddlers, and children weighing &lt;10 kg</th>\r\n\t\t\t\t\t<th>Children weighing &gt;10 kg and &lt;33 kg</th>\r\n\t\t\t\t\t<th>Children, adolescents, and adults weighing &gt;33 kg and &lt;50 kg</th>\r\n\t\t\t\t\t<th>Adolescents and adults weighing &gt;50 kg</th>\r\n\t\t\t\t</tr>\r\n\t\t\t\t<tr>\r\n\t\t\t\t\t<td><strong>Dose<br>      (per administration)</strong></td>\r\n\t\t\t\t\t<td>One intravenous infusion of 7&middot;5 mg/kg:<br>\r\n\t\t\t\t\t\t<strong>ie, 0&middot;75 mL solution per kg</strong></td>\r\n\t\t\t\t\t<td>One intravenous infusion of 15 mg/kg:<br>\r\n\t\t\t\t\t\t<strong>ie, 1&middot;5 mL solution per kg</strong></td>\r\n\t\t\t\t\t<td>One intravenous infusion of 15 mg/kg:<br>\r\n\t\t\t\t\t\t<strong>ie, 1&middot;5 mL solution per kg</strong></td>\r\n\t\t\t\t\t<td>One intravenous infusion of 1 g:<br>\r\n\t\t\t\t\t\t<strong>ie, 100 mL solution</strong></td>\r\n\t\t\t\t</tr>\r\n\t\t\t\t<tr>\r\n\t\t\t\t\t<td><strong>Maximum<br>      daily dose</strong></td>\r\n\t\t\t\t\t<td><strong>30 mg/kg (ie, 3 mL/kg)</strong></td>\r\n\t\t\t\t\t<td>60 mg/kg<br>\r\n\t\t\t\t\t\t<strong>(ie, 6 mL/kg)</strong><br>      without exceeding<br>      2 g <strong>(ie, 200 mL)</strong><br>      in total</td>\r\n\t\t\t\t\t<td>60 mg/kg<br>\r\n\t\t\t\t\t\t<strong>(ie, 6 mL/kg)</strong><br>      without exceeding 3 g <strong>(ie, 300 mL)</strong><br>      in total</td>\r\n\t\t\t\t\t<td>Must not exceed 4 g<br>\r\n\t\t\t\t\t\t<strong>(ie, 400 mL)</strong><br>      in total</td>\r\n\t\t\t\t</tr>\r\n\t\t\t</tbody></table><p>Note: maximum daily dose in each dose range refers to that for maximum weight in each range.</p><h2>Infants and children</h2><p>Up to May 31 2010, 23 cases of accidental overdose with Perfalgan have been reported worldwide in children younger than 1 year, one of which was fatal. In the UK, there have been seven reports of overdose in infants and neonates. In most of these cases, a 10-fold overdose was reported.</p><p>See <a href=\"http://www.mhra.gov.uk/Safetyinformation/Safetywarningsalertsandrecalls/Safetywarningsandmessagesformedicines/Monthlylistsofinformationforhealthcareprofessionalsonthesafetyofmedicines/CON084656\" title=\"Information sent to healthcare professionals in May 2010 about the safety of medicines\">Information sent to healthcare professionals in May 2010 about the safety of medicines</a></p><p>A dosing table for infants and children of different weights is provided below:</p><table class=\"standard\" style=\"WIDTH: 696px; HEIGHT: 277px\">\r\n\t\t\t<tbody>\r\n\t\t\t\t<tr>\r\n\t\t\t\t\t<th>Paracetamol dose<br>      (mg/kg)</th>\r\n\t\t\t\t\t<th>Weight<br>      (kg)</th>\r\n\t\t\t\t\t<th>Calculated dose<br>      (mg)</th>\r\n\t\t\t\t\t<th>Volume of solution<br>      (mL)</th>\r\n\t\t\t\t</tr>\r\n\t\t\t\t<tr>\r\n\t\t\t\t\t<th colspan=\"4\">Infants and children weighing &le;10 kg</th>\r\n\t\t\t\t</tr>\r\n\t\t\t\t<tr>\r\n\t\t\t\t\t<td rowspan=\"4\">7&middot;5</td>\r\n\t\t\t\t\t<td>3</td>\r\n\t\t\t\t\t<td>22.5</td>\r\n\t\t\t\t\t<td>2.25</td>\r\n\t\t\t\t</tr>\r\n\t\t\t\t<tr>\r\n\t\t\t\t\t<td>5</td>\r\n\t\t\t\t\t<td>37.5</td>\r\n\t\t\t\t\t<td>3.75</td>\r\n\t\t\t\t</tr>\r\n\t\t\t\t<tr>\r\n\t\t\t\t\t<td>7</td>\r\n\t\t\t\t\t<td>52.5</td>\r\n\t\t\t\t\t<td>5.25</td>\r\n\t\t\t\t</tr>\r\n\t\t\t\t<tr>\r\n\t\t\t\t\t<td>10</td>\r\n\t\t\t\t\t<td>75</td>\r\n\t\t\t\t\t<td>7.5</td>\r\n\t\t\t\t</tr>\r\n\t\t\t\t<tr>\r\n\t\t\t\t\t<th colspan=\"4\">Children weighing &gt;10 kg</th>\r\n\t\t\t\t</tr>\r\n\t\t\t\t<tr>\r\n\t\t\t\t\t<td rowspan=\"4\">15</td>\r\n\t\t\t\t\t<td>15</td>\r\n\t\t\t\t\t<td>225</td>\r\n\t\t\t\t\t<td>22.5</td>\r\n\t\t\t\t</tr>\r\n\t\t\t\t<tr>\r\n\t\t\t\t\t<td>20</td>\r\n\t\t\t\t\t<td>300</td>\r\n\t\t\t\t\t<td>30</td>\r\n\t\t\t\t</tr>\r\n\t\t\t\t<tr>\r\n\t\t\t\t\t<td>30</td>\r\n\t\t\t\t\t<td>450</td>\r\n\t\t\t\t\t<td>45</td>\r\n\t\t\t\t</tr>\r\n\t\t\t</tbody></table><div class=\"dull_highlight\">\r\n\t\t\t<p><strong>Advice for healthcare professionals:</strong></p>\r\n\t\t\t<ul>\r\n\t\t\t\t<li>Vigilance is advised when prescribing and administering Perfalgan to ensure that the correct dose is given, especially in infants and neonates where there is a risk of confusion due to prescription in mg and administration in mL</li>\r\n\t\t\t\t<li>For all patients on the basis of their weight, adhere to the recommended dose as outlined above and in the product information; the dosing schedule is up to four infusions a day with a minimum of 4 hours between each administration, 6 hours for those with renal impairment</li>\r\n\t\t\t\t<li>For infants and children who weigh less than 33 kg, the 50 mL vial should be used</li>\r\n\t\t\t\t<li>In order to avoid overdose, intravenous paracetamol should not be given concomitantly with oral paracetamol, including combination products</li>\r\n\t\t\t</ul></div><h2>Reporting of suspected adverse reactions</h2><p>Perfalgan is under intensive monitoring (&#9660;) by the MHRA, and healthcare professionals are reminded to report all suspected adverse reactions promptly via the Yellow Card Scheme (see <a href=\"http://www.yellowcard.gov.uk/\" target=\"_blank\" title=\"Yellow Card Scheme\">www.yellowcard.gov.uk</a>).</p><p>&nbsp;</p><p><em>Article citation: Drug Safety Update July 2010, vol 3 issue 12: 2.</em></p>-->\r\n\t\t\t\t\t\t\t\t<!--SS_END_ELEMENT(region1_element13)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!-- SS_BEGIN_SNIPPET(fragment7,1)-->\r\n\t\t\t\t\t\t\t\t<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t<p>Cases of accidental overdose have been reported during treatment with intravenous paracetamol 10 mg/mL solution for infusion (Perfalgan &#9660;). In most cases, this occurred in infants and neonates due to confusion between the prescription of Perfalgan being issued in mg and then administered in mL; in most of these cases, a 10-fold overdose was reported.</p><p>Perfalgan is indicated for the short-term treatment of pain and fever, when there is a clinical need of paracetamol administration intravenously. It is available as a solution for infusion of 10 mg paracetamol per 1 mL solution in 50 mL vials and 100 mL vials. The 50 mL vial is only for use in term newborn infants, infants, toddlers, and children who weigh less than 33 kg.</p><p>The recommended dose of Perfalgan depends on the weight of the patient, and is summarised in the table below.</p><p><strong>Note</strong> that irrespective of dose, the dosing schedule is up to four infusions a day with a minimum of 4 hours between each administration (6 hours for those with renal impairment).</p><table class=\"standard\">\r\n\t\t\t<tbody>\r\n\t\t\t\t<tr>\r\n\t\t\t\t\t<th></th>\r\n\t\t\t\t\t<th>Term newborn infants, infants, toddlers, and children weighing &lt;10 kg</th>\r\n\t\t\t\t\t<th>Children weighing &gt;10 kg and &lt;33 kg</th>\r\n\t\t\t\t\t<th>Children, adolescents, and adults weighing &gt;33 kg and &lt;50 kg</th>\r\n\t\t\t\t\t<th>Adolescents and adults weighing &gt;50 kg</th>\r\n\t\t\t\t</tr>\r\n\t\t\t\t<tr>\r\n\t\t\t\t\t<td><strong>Dose<br>      (per administration)</strong></td>\r\n\t\t\t\t\t<td>One intravenous infusion of 7&#183;5 mg/kg:<br>\r\n\t\t\t\t\t\t<strong>ie, 0&#183;75 mL solution per kg</strong></td>\r\n\t\t\t\t\t<td>One intravenous infusion of 15 mg/kg:<br>\r\n\t\t\t\t\t\t<strong>ie, 1&#183;5 mL solution per kg</strong></td>\r\n\t\t\t\t\t<td>One intravenous infusion of 15 mg/kg:<br>\r\n\t\t\t\t\t\t<strong>ie, 1&#183;5 mL solution per kg</strong></td>\r\n\t\t\t\t\t<td>One intravenous infusion of 1 g:<br>\r\n\t\t\t\t\t\t<strong>ie, 100 mL solution</strong></td>\r\n\t\t\t\t</tr>\r\n\t\t\t\t<tr>\r\n\t\t\t\t\t<td><strong>Maximum<br>      daily dose</strong></td>\r\n\t\t\t\t\t<td><strong>30 mg/kg (ie, 3 mL/kg)</strong></td>\r\n\t\t\t\t\t<td>60 mg/kg<br>\r\n\t\t\t\t\t\t<strong>(ie, 6 mL/kg)</strong><br>      without exceeding<br>      2 g <strong>(ie, 200 mL)</strong><br>      in total</td>\r\n\t\t\t\t\t<td>60 mg/kg<br>\r\n\t\t\t\t\t\t<strong>(ie, 6 mL/kg)</strong><br>      without exceeding 3 g <strong>(ie, 300 mL)</strong><br>      in total</td>\r\n\t\t\t\t\t<td>Must not exceed 4 g<br>\r\n\t\t\t\t\t\t<strong>(ie, 400 mL)</strong><br>      in total</td>\r\n\t\t\t\t</tr>\r\n\t\t\t</tbody></table><p>Note: maximum daily dose in each dose range refers to that for maximum weight in each range.</p><h2>Infants and children</h2><p>Up to May 31 2010, 23 cases of accidental overdose with Perfalgan have been reported worldwide in children younger than 1 year, one of which was fatal. In the UK, there have been seven reports of overdose in infants and neonates. In most of these cases, a 10-fold overdose was reported.</p><p>See <a href=\"http://www.mhra.gov.uk/Safetyinformation/Safetywarningsalertsandrecalls/Safetywarningsandmessagesformedicines/Monthlylistsofinformationforhealthcareprofessionalsonthesafetyofmedicines/CON084656\" title=\"Information sent to healthcare professionals in May 2010 about the safety of medicines\">Information sent to healthcare professionals in May 2010 about the safety of medicines</a></p><p>A dosing table for infants and children of different weights is provided below:</p><table class=\"standard\" style=\"WIDTH: 696px; HEIGHT: 277px\">\r\n\t\t\t<tbody>\r\n\t\t\t\t<tr>\r\n\t\t\t\t\t<th>Paracetamol dose<br>      (mg/kg)</th>\r\n\t\t\t\t\t<th>Weight<br>      (kg)</th>\r\n\t\t\t\t\t<th>Calculated dose<br>      (mg)</th>\r\n\t\t\t\t\t<th>Volume of solution<br>      (mL)</th>\r\n\t\t\t\t</tr>\r\n\t\t\t\t<tr>\r\n\t\t\t\t\t<th colspan=\"4\">Infants and children weighing &#8804;10 kg</th>\r\n\t\t\t\t</tr>\r\n\t\t\t\t<tr>\r\n\t\t\t\t\t<td rowspan=\"4\">7&#183;5</td>\r\n\t\t\t\t\t<td>3</td>\r\n\t\t\t\t\t<td>22.5</td>\r\n\t\t\t\t\t<td>2.25</td>\r\n\t\t\t\t</tr>\r\n\t\t\t\t<tr>\r\n\t\t\t\t\t<td>5</td>\r\n\t\t\t\t\t<td>37.5</td>\r\n\t\t\t\t\t<td>3.75</td>\r\n\t\t\t\t</tr>\r\n\t\t\t\t<tr>\r\n\t\t\t\t\t<td>7</td>\r\n\t\t\t\t\t<td>52.5</td>\r\n\t\t\t\t\t<td>5.25</td>\r\n\t\t\t\t</tr>\r\n\t\t\t\t<tr>\r\n\t\t\t\t\t<td>10</td>\r\n\t\t\t\t\t<td>75</td>\r\n\t\t\t\t\t<td>7.5</td>\r\n\t\t\t\t</tr>\r\n\t\t\t\t<tr>\r\n\t\t\t\t\t<th colspan=\"4\">Children weighing &gt;10 kg</th>\r\n\t\t\t\t</tr>\r\n\t\t\t\t<tr>\r\n\t\t\t\t\t<td rowspan=\"4\">15</td>\r\n\t\t\t\t\t<td>15</td>\r\n\t\t\t\t\t<td>225</td>\r\n\t\t\t\t\t<td>22.5</td>\r\n\t\t\t\t</tr>\r\n\t\t\t\t<tr>\r\n\t\t\t\t\t<td>20</td>\r\n\t\t\t\t\t<td>300</td>\r\n\t\t\t\t\t<td>30</td>\r\n\t\t\t\t</tr>\r\n\t\t\t\t<tr>\r\n\t\t\t\t\t<td>30</td>\r\n\t\t\t\t\t<td>450</td>\r\n\t\t\t\t\t<td>45</td>\r\n\t\t\t\t</tr>\r\n\t\t\t</tbody></table><div class=\"dull_highlight\">\r\n\t\t\t<p><strong>Advice for healthcare professionals:</strong></p>\r\n\t\t\t<ul>\r\n\t\t\t\t<li>Vigilance is advised when prescribing and administering Perfalgan to ensure that the correct dose is given, especially in infants and neonates where there is a risk of confusion due to prescription in mg and administration in mL</li>\r\n\t\t\t\t<li>For all patients on the basis of their weight, adhere to the recommended dose as outlined above and in the product information; the dosing schedule is up to four infusions a day with a minimum of 4 hours between each administration, 6 hours for those with renal impairment</li>\r\n\t\t\t\t<li>For infants and children who weigh less than 33 kg, the 50 mL vial should be used</li>\r\n\t\t\t\t<li>In order to avoid overdose, intravenous paracetamol should not be given concomitantly with oral paracetamol, including combination products</li>\r\n\t\t\t</ul></div><h2>Reporting of suspected adverse reactions</h2><p>Perfalgan is under intensive monitoring (&#9660;) by the MHRA, and healthcare professionals are reminded to report all suspected adverse reactions promptly via the Yellow Card Scheme (see <a href=\"http://www.yellowcard.gov.uk/\" target=\"_blank\" title=\"Yellow Card Scheme\">www.yellowcard.gov.uk</a>).</p><p>&#160;</p><p><em>Article citation: Drug Safety Update July 2010, vol 3 issue 12: 2.</em></p>\r\n\t\t\t\r\n\t\t\t\t\t\t\t\t<!-- SS_END_SNIPPET(fragment7,1)-->\r\n\t\t\t\t\t\t\t</div>\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t", 
  "date_of_article": "2010-07-01", 
  "date_last_modified": "2010-09-17", 
  "_assets": [], 
  "_item_id": 194, 
  "summary": "Vigilance is advised when prescribing and administering intravenous paracetamol 10 mg/mL solution for infusion (Perfalgan ▼) to ensure that the correct dose is given. For all patients, dose requirement is based on weight as outlined below and in the product information. For infants and children who weigh less than 33 kg, the 50 mL vial should be used for administration", 
  "body": "Article date: July 2010\n\nCases of accidental overdose have been reported during treatment with intravenous paracetamol 10 mg/mL solution for infusion (Perfalgan ▼). In most cases, this occurred in infants and neonates due to confusion between the prescription of Perfalgan being issued in mg and then administered in mL; in most of these cases, a 10-fold overdose was reported.\n\nPerfalgan is indicated for the short-term treatment of pain and fever, when there is a clinical need of paracetamol administration intravenously. It is available as a solution for infusion of 10 mg paracetamol per 1 mL solution in 50 mL vials and 100 mL vials. The 50 mL vial is only for use in term newborn infants, infants, toddlers, and children who weigh less than 33 kg.\n\nThe recommended dose of Perfalgan depends on the weight of the patient, and is summarised in the table below.\n\nNote that irrespective of dose, the dosing schedule is up to four infusions a day with a minimum of 4 hours between each administration (6 hours for those with renal impairment).  \n  \n |   | Term newborn infants, infants, toddlers, and children weighing <10 kg |   | Children weighing >10 kg and <33 kg |   | Children, adolescents, and adults weighing >33 kg and <50 kg |   | Adolescents and adults weighing >50 kg |   \n-|-  \nDose (per administration) |   | One intravenous infusion of 7·5 mg/kg: ie, 0·75 mL solution per kg |   | One intravenous infusion of 15 mg/kg: ie, 1·5 mL solution per kg |   | One intravenous infusion of 15 mg/kg: ie, 1·5 mL solution per kg |   | One intravenous infusion of 1 g: ie, 100 mL solution |   \nMaximum daily dose |   | 30 mg/kg (ie, 3 mL/kg) |   | 60 mg/kg (ie, 6 mL/kg) without exceeding 2 g (ie, 200 mL) in total |   | 60 mg/kg (ie, 6 mL/kg) without exceeding 3 g (ie, 300 mL) in total |   | Must not exceed 4 g (ie, 400 mL) in total | \n\nNote: maximum daily dose in each dose range refers to that for maximum weight in each range.\n\n## Infants and children\n\nUp to May 31 2010, 23 cases of accidental overdose with Perfalgan have been reported worldwide in children younger than 1 year, one of which was fatal. In the UK, there have been seven reports of overdose in infants and neonates. In most of these cases, a 10-fold overdose was reported.\n\nSee [Information sent to healthcare professionals in May 2010 about the safety of medicines](http://www.mhra.gov.uk/Safetyinformation/Safetywarningsalertsandrecalls/Safetywarningsandmessagesformedicines/Monthlylistsofinformationforhealthcareprofessionalsonthesafetyofmedicines/CON084656)\n\nA dosing table for infants and children of different weights is provided below:  \n  \nParacetamol dose (mg/kg) |   | Weight (kg) |   | Calculated dose (mg) |   | Volume of solution (mL) |   \nInfants and children weighing ≤10 kg |   \n-|-  \n7·5 |   | 3 |   | 22.5 |   | 2.25 |   \n5 |   | 37.5 |   | 3.75 |   \n7 |   | 52.5 |   | 5.25 |   \n10 |   | 75 |   | 7.5 |   \nChildren weighing >10 kg |   \n15 |   | 15 |   | 225 |   | 22.5 |   \n20 |   | 300 |   | 30 |   \n30 |   | 450 |   | 45 | \n\nAdvice for healthcare professionals:  \n  \n  * Vigilance is advised when prescribing and administering Perfalgan to ensure that the correct dose is given, especially in infants and neonates where there is a risk of confusion due to prescription in mg and administration in mL  \n  * For all patients on the basis of their weight, adhere to the recommended dose as outlined above and in the product information; the dosing schedule is up to four infusions a day with a minimum of 4 hours between each administration, 6 hours for those with renal impairment  \n  * For infants and children who weigh less than 33 kg, the 50 mL vial should be used  \n  * In order to avoid overdose, intravenous paracetamol should not be given concomitantly with oral paracetamol, including combination products  \n  \n## Reporting of suspected adverse reactions\n\nPerfalgan is under intensive monitoring (▼) by the MHRA, and healthcare professionals are reminded to report all suspected adverse reactions promptly via the Yellow Card Scheme (see [www.yellowcard.gov.uk](http://www.yellowcard.gov.uk/)).\n\n \n\nArticle citation: Drug Safety Update July 2010, vol 3 issue 12: 2.\n"
}